改良胰岛素给药方案对重症急性胰腺炎血糖波动和预后的影响

王霆; 丁俊华; 姜岱山; 李山峰; 蔡琦; 刘春

doi:10.13201/j.issn.1009-5918.2020.12.013

改良胰岛素给药方案对重症急性胰腺炎血糖波动和预后的影响

- 南通大学附属医院急诊医学科(江苏南通, 226001)

详细信息

通讯作者: 王霆,E-mail:poorot2001@msn.com

收稿日期: 2020-08-11

Effect of modified insulin administration regimen on blood glucose fluctuation and prognosis in severe acute pancreatitis

- Department of Emergency Medicine, the Affiliated Hospital of Nantong University, Nantong, Jiangsu, 226001, China

More Information

Corresponding author: WANG Ting, E-mail: poorot2001@msn.com

Received Date: 11 August 2020

摘要

摘要: 目的:探讨一种改良胰岛素给药方案对重症急性胰腺炎(SAP)患者血糖波动和预后的影响。方法:选择南通大学附属医院急诊重症监护室(EICU)收治的32例SAP患者为研究对象,随机分为试验组和对照组,对照组采用常规胰岛素(RI)给药方案;试验组采用改良方案,即根据单位时间内摄入葡萄糖量,按照葡萄糖4 g:胰岛素1 U同步给予RI。每2 h测末梢血糖,记录、计算并比较两组患者入院初始血糖(BGad)、72 h平均血糖(BGm)和标准差(BGsd)、血糖变异系数(BGcv)、血糖不稳定指数(BGI)和低血糖发生率。比较两组患者入院时和入院72 h后白细胞计数(WBC)、超敏C反应蛋白(CRP)、降钙素原(PCT)的水平。记录并比较两组患者28 d病死率。结果:两组患者BGad、BGm、WBC、CRP、PCT无显著差异(P>0.05)。试验组患者72 h的BGsd、BGcv、BGI小于对照组(P<0.05),低血糖发生率与对照组差异无统计学意义(P>0.05)。试验组患者入院72 h后CRP和PCT较对照组有改善(P<0.05)。两组患者28天死亡率差异无统计学意义(P>0.05)。结论:对于SAP患者,改良胰岛素给药方案可以减少血糖波动,减轻炎症反应,但目前证据不足以支持改善28 d病死率。
- 改良胰岛素给药方案 /
- 急性重症胰腺炎 /
- 血糖变异系数 /
- 血糖不稳定指数
Abstract: Objective:To investigate the effect of modified insulin administration regimen on blood glucose fluctuation and prognosis in patients with severe acute pancreatitis(SAP).Methods:A total of 32 SAP patients admitted to the emergency intensive care unit(EICU) were randomly divided into the experimental group and the control group. The control group was given conventional insulin administration, and the experimental group was given the modified scheme——according to the amount of glucose intake per unit time, insulin was given in the proportion of glucose 4 g:insulin 1 U at the same time. The peripheral blood glucose was measured every 2 hours. The initial blood glucose(BGad), 72 h mean blood glucose(BGm), standard deviation(BGsd), coefficient of blood glucose variability(BGcv), blood glucose instability index(BGI) and hypoglycemia incidence were recorded, calculated and compared between the two groups. The levels of white blood cell count(WBC), high sensitivity C-reactive protein(CRP) and procalcitonin(PCT) were compared between the two groups at admission and 72 hours after admission. The 28 d mortality was recorded and compared between the two groups.Results:There was no significant difference in BGad, BGm, WBC, CRP and PCT between the two groups(P>0.05). The BGsd, BGcv and BGI of the experimental group were lower than those of the control group(P<0.05), and the incidence of hypoglycemia was not significantly different from that of the control group(P>0.05). The CRP and PCT of the experimental group were better than those of the control group at 72 hours after admission(P<0.05). There was no significant difference in 28 day mortality between the two groups(P>0.05).Conclusion:For SAP patients, the modified insulin administration can reduce blood glucose fluctuation and inflammatory response, but the current evidence is not enough to support the improvement of 28 day mortality.
- modified insulin administration /
- severe acute pancreatitis(SAP) /
- coefficient of blood glucose variability(BGcv) /
- blood glucose instability index(BGI)

HTML全文

参考文献(21)

[1]	Sandler RS,Everhart JE,Donowitz M,et al.The burden of selected digestive diseases in the United States[J].Gastroenterology.2002,122(5):1500-1511.
[2]	Rizzo MR,Barbieri M,Marfella R,et al..Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes:role of dipeptidyl peptidase-IV inhibition[J].Diabetes Care.2012,35(10):2076-2082.
[3]	周淑琴,张守法,张伟,等.姜黄素对波动性高血糖处理下人脐静脉内皮细胞DNA氧化损伤的影响[J].中国老年学杂志,2018,38(5):1205-1207.
[4]	祁玮,黄飞,徐洋,等.重症胰腺炎患者血糖异常波动程度与28天病死率之间的相关性分析[J].内科急危重症杂志,2019,25(3):210-212,226.
[5]	Dedemadi G,Nikolopoulos M,Kalaitzopoulos I,et al.Management of patients after recovering from acute severe biliary pancreatitis[J].World J Gastroenterol,2016,22(34):7708-7717.
[6]	伍静,孙秋虹,杨华.不同血糖控制方案对急性重症胰腺炎患者血糖变异性的影响[J].中华医学杂志,2015,95(19):1496-1500.
[7]	中华医学会消化病学分会胰腺疾病学组,中华胰腺病杂志编辑委员会,中华消化杂志编辑委员会.中国急性胰腺炎诊治指南(2019年,沈阳)[J].中华消化杂志,2019,39(11):721-730.
[8]	Ellahham S.Insulin therapy in critically ill patients[J].Vasc Health Risk Manag,2010,6(1):1089-1101.
[9]	McMahon MM,Nystrom E,Braunschweig C,et al.A.S.P.E.N.clinical guidelines:nutrition support of adult patients with hyperglycemia[J].JPEN J Parenter Enteral Nutr,2013,37(1):23-36.
[10]	张利鹏,郭媛博,周丽华.重症患者血糖不稳定指数对短期预后价值分析[J].中华医学杂志,2016,96(21):1656-1659.
[11]	王先令,陆菊明.血糖波动对糖尿病预后及其慢性并发症发生发展的影响[J].国际内分泌代谢杂志,2005,25(3):169-171.
[12]	Krenitsky J.Glucose control in the intensive care unit:a nutrition support perspective[J].Nutr Clin Pract,2011,26(1):31-43.
[13]	Gunst J,De Bruyn A,Van den Berghe G.Glucose control in the ICU.Curr Opin Anaesthesiol[J].2019,32(2):156-162.
[14]	焦作义,尚轶,罗长江,等.早期强化与适度胰岛素治疗对重症急性胰腺炎患者预后的影响[J].中华消化外科杂志,2012,11(4):327-330.
[15]	Rodbard D.Glucose Variability:A Review of Clinical Applications and Research Developments[J].Diabetes Technol Ther.2018,20(S2):S25-S215.
[16]	Kovatchev B,Cobelli C.Glucose Variability:Timing,Risk Analysis,and Relationship to Hypoglycemia in Diabetes.Diabetes Care.2016,39(4):502-510.
[17]	白金川,陈更业,马云涛,等.慢性阻塞性肺病急性加重期患者血糖浓度变化[J].中国老年学杂志,2019,39(12):2910-2911.
[18]	蒋建红,王勇,刘文明,等.血糖波动系数及CRP水平对危重症患者预后的评估价值 [J].临床急诊杂志,2015,16(6):607-609.
[19]	董裕康,梁显泉,虞晓红,等.严重多发伤患者早期血糖变异度与预后的相关性研究[J].临床急诊杂志,2015,16(10):764-767.
[20]	施莉,韦炜,向华,等.强化血糖控制对重症急性胰腺炎患者血糖变异性及预后的影响[J].中华胰腺病杂志,2014,14(2):120-122.
[21]	徐益萍,骆方军,郑军,等.重症急性胰腺炎患者血清降钙素原与C-反应蛋白测定的临床价值[J].中华医院感染学杂志,2017,27(5):1089-1092.